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Abstract
Background: Patient Activation is defined as the knowledge, skill, and confidence a patient has in managing their
health. Higher levels of patient activation are associated with better self-management, better health outcomes, and
lower healthcare costs. Understanding the drivers of patient activation can allow better tailoring of patient support
and interventions. There are few data on patient activation in UK patients with long-term conditions.
Methods: A prospective cohort design was used. Questionnaires were mailed to 12,989 patients over the age of
65 years with at least one long-term condition in Salford, UK. They completed the Patient Activation Measure and
self-report measures of: depression, health literacy, social support, health-related quality of life, and impact of
multimorbidity. We report descriptive data on baseline activation and change over time, and use multivariate
regression to model associations with patient activation at baseline and predictors of change in Activation over
6 months.
Results: The cohort included 4377 (33.6 %) older people, of whom 4225 were mailed a further questionnaire at
6 months; 3390 returned it complete (80.2 %). At baseline, 15 % self-reported PAM level 1, 16 % level 2, 45 %
level 3, and 25 % level 4. Across all patients, depression had the strongest association with patient activation.
Other important factors were: older age, being retired, poor health literacy, health-related quality of life, and
social support. Total number of self-reported comorbidities and the perceived impact of comorbidities were
also important for patients with more than one long-term condition.
Patient activation scores were reasonably enduring over time (r = 0.43 between baseline and at six months),
although nearly half changed ‘levels’ of activation over that time. Few variables predicted change in activation
over 6 months.
Conclusions: This is the first large scale assessment of patient activation in the UK. Our data may be useful in identifying
patients who need support with patient activation, and allow interventions (such as health coaching) to be tailored to
better support older patients with long-term conditions who have symptoms of depression, poor social support and
impaired health literacy. Further analyses of longitudinal studies will be necessary to better understand the causal
relationships between patient activation and variables such as depression.
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Background
Managing long-term conditions and multimorbidity are
key challenges for health care systems, and require a ‘whole
systems perspective’ involving patients, practitioners, and
service reorganisation [1]. The Chronic Care Model is an
well-known exemplar of such a perspective [2].
Supported patient self-management is a widely used
strategy for trying to address the challenges of managing
long-term conditions and multimorbidity, including help-
ing patients to change lifestyle behaviours and to learn
core skills, such as responding to symptoms, managing
medicine, improving diet, increasing exercise, stopping
smoking, and managing interactions with professionals
[3]. In the Chronic Care Model, people who achieve this
are described as a ‘informed, activated patients’ [4].
The challenge of supporting self-management has
been tackled in a variety of ways. Although information
and education are necessary, they are rarely sufficient,
and greater focus has been placed on behaviour change.
However, even this may not be sufficient [5] and there
has been increasing interest in the role of psychological
variables relating to the attitudes and perceptions of the
patient. Self-efficacy (a sense of control over actions and
outcomes) has been hypothesised to be a key driver,
[6] and was the basis for the Chronic Disease Self-
Management Programme in the US (styled the Expert
Patients Programme in the UK) [7]. Self-efficacy was
initially hypothesised to be a potential mediator of the
benefits of interventions for long-term conditions: [8, 9]
that is, changes in self-efficacy were the mechanism by
which the benefits were actually achieved [5]. Evidence
also suggests that self-efficacy can be a moderator of out-
comes: that is, it predicts which patients may benefit. Low
baseline self-efficacy predicted additional benefit from the
Expert Patients Programme [10].
Given these important effects, there is ongoing interest
in the identification of patient characteristics that can
help understand which patients might benefit most from
supported self-management. This would allow services
to better understand patient needs, target support,
and measure quality. One such characteristic is patient
activation.
Patient activation
Patient activation is defined as how well a patient under-
stands their own role in the healthcare process; and their
level of knowledge, skill, and confidence in managing their
own health [11]. Hibbard et al. (2005) describes four stages
or levels of patient activation which range from those who
are passive recipients of care, unable to self-manage, to
those who are effective self-managers but may need some
additional support during times of stress or crisis [12].
Improving patient activation is increasingly seen as
an important component of new strategies to reform
healthcare and improve health outcomes [13]. There is
a growing body of evidence that patients who are
more ‘activated’ have better health outcomes as well as
an improved care experience [8]. In a US sample of
mostly female patients with moderate to severe de-
pression, level of patient activation was found to pre-
dict remission or improvement from depression over
12 months [14]. Depressed patients who were better
activated were also more likely to engage in healthy
behaviour changes such as quitting smoking and los-
ing weight, and more likely to attend smear tests and
mammogram screening [14].
NHS England (the body of the UK Department of
Health which plans and oversees delivery of the English
NHS) has identified patient activation as a potentially
useful tool in the development of services to meet the
needs of patients with long-term conditions [15]. Despite
the interest in patient activation, there is relatively little
data from UK patients. We use an existing cohort of pa-
tients aged 65+ with long-term conditions to describe
levels of patient activation in the cohort, and to explore
factors that predict change in activation over time.
Method
We conducted a prospective cohort study of older people
as part of the Comprehensive Longitudinal Assessment of
Salford Integrated Care (CLASSIC) study. Eligible partici-
pants were those aged 65 years or older who were regis-
tered as having at least one long-term condition at a
general practice in Salford (a city in the North West of
England). Salford has a population of 294,916 (34,000 aged
over 65 years) and a total of 52 general practices which
are clustered in 8 neighbourhoods. Forty seven general
practices in Salford were invited to take part in the study
and 33 (65 %) agreed to participate.
We used the FARSITE software (a tool for recruitment
to research studies in primary care - http://nweh.co.uk/
products/farsite) to generate a list of eligible patients for
each participating general practice. Each practice was then
asked to identify any patients who met the exclusion cri-
teria (patients in palliative care, and those with conditions
which reduce capacity to consent and participate). Prac-
tices did not receive any incentive to take part but did
receive support costs to reimburse them for their time.
A total of 12,989 patients were identified as eligible and
were therefore mailed a questionnaire between November
2014 and February 2015. If they did not return the first
questionnaire they were sent a reminder letter and a
second copy of the questionnaire 3 weeks later. Partici-
pants were offered a £10 voucher on completion of the
questionnaire as an incentive. Follow-up questionnaires
were sent 6 months later (there was no incentive for
completion of follow-up) to allow exploration of change
over time.
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Outcome measure - patient activation
We used the 13 item version of the Patient Activation
Measure (PAM) [13]. The PAM consists of 13 state-
ments relating to patients beliefs about health care, con-
fidence in their management of health related tasks, and
self-assessed knowledge of their condition [13]. For each
statement patients are required to say how much they
either agree or disagree on a response scale of 1–5,
where 1 represents “strongly disagree”, 4 represents
“strongly agree” and 5 indicates that the statement is
“not applicable” to them. A standardised spreadsheet in
excel is used to score the PAM. Responses are used to
generate a continuous score from 0 to 100 where higher
scores indicate that the patient is more activated [13].
Where participants have answered that a statement is
not applicable to them the data is treated as missing. A
total score is generated where participants have an-
swered at least 10 out of the 13 questions.
The continuous PAM scores are then categorised into
four levels for descriptive purposes using the standar-
dised excel spreadsheet. Those who fall into Level 1 are
defined as passive recipients of care who do not under-
stand that they can play an active role in their own
healthcare. Level 2 includes patients who lack the basic
knowledge and confidence to effectively self-manage (for
example they may not understand the treatment options
available to them or what their medications do). Level 3
includes those who have a basic knowledge about their
health but they lack the confidence and skills to engage
in positive self-management behaviours. Level 4 is for
patients who have the knowledge and confidence to self-
manage but who may need support during times of per-
sonal stress or health crisis [12].
The PAM has been found to be a valid and reliable
measure in people with long-term conditions, such as
those attending cardiac rehabilitation,[11] and in those
patients with multimorbidity [16]. We used the continuous
PAM score in the analyses.
Predictor variables
(a)Socio-demographics
We assessed age, gender, current work status and
qualifications using questions taken from the
General Practice Patient Survey [17]. We also asked
participants to tell us if they lived alone, or with a
spouse/partner, children (over or under 18 years
old). Ethnicity was assessed using the 17 categories
from the 2011 Census.
Health literacy was assessed using the Single Item
Literacy Screener (SILS) which asks patients to
report how often they need help with reading
information, pamphlets, or other written material
from their doctor or pharmacy [18]. This question
has demonstrated good reliability and validity and
been previously used in adults with long term
conditions [18, 19].
(b)Long-term conditions and multimorbidity
We used a questionnaire to measure number self-
reported long-term conditions for each patient and
their impact on daily life [20]. Participants were
given a list of 24 common long-term conditions and
asked whether or not they had each condition and if
they did how it interfered with their daily life (5 point
scale ranging from 1 ‘not at all’ to 5 ‘a lot’). The
conditions were: asthma; cancer; back pain; COPD;
CKD; IBS; heart failure; depression and anxiety;
diabetes; hearing problems; vision problems; heart
disease; high blood pressure; high cholesterol;
osteoarthritis; rheumatoid arthritis; osteoporosis;
obesity; poor circulation; rheumatic disease; stomach
problems; stroke; thyroid disorder; and other.
(c)Health related quality of life
We used the EuroQol EQ-5D-5 L health utility
index as a measure of health related quality of life
[21]. The EQ-5D is a measure of general HRQoL
which consists of the EQ-5D descriptive system and
the EQ Visual Analogue Scale (EQ VAS). The EQ-5D
has 5 domains: mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression. Participants
are asked to record their health today for each domain
where 1 indicates that they have no problems in that
domain and 5 indicates that they have extreme
problems. We used the recommended crosswalk
tool to map the EQ-5D-5 L responses to validated
utility scores based on the previous 3-level version
of the EQ-5D [22]. The EQ-5D-5 L has been found
to be a valid and reliable extension to the 3 level
system [23] and has better measurement properties
than the 3 level system for patients with long-term
conditions and multimorbidity [24].
(d)Depression
The co-existence of depression alongside other long-
term conditions is prevalent and associated with
significant impacts on health and costs [25]. The
Mental Health Inventory-5 (MHI-5) was used to
assess patient’s mood [26, 27]. The MHI-5 is a 5
item measure which asks patients to rate how much
of the time they have felt happy, calm, nervous, or
downhearted over the previous month. The measure
has been well validated for identifying symptoms of
depression [28, 29]. We used a cut off of a score of 60
to indicate presence of symptoms of depression, where
a higher score indicates better mental health [29].
(e)Social support
The ENRICHD Social Support instrument (ESSI)
is a 7 item scale which was used to measure social
support [30]. The scale covers partners, tangible
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help and emotional support. A total score is
calculated by summing all individual items; a
higher score indicates greater social support.
(f ) Perceived impact of multimorbidity
Where patients have more than one long-term condi-
tion, they often face significant logistical and emotional
challenges in managing the burden of their treatment,
as well as the burden of disease [31, 32]. For participants
who self-reported two or more long term conditions we
used a 16 item version of the MULTIPleS scale of illness
perceptions [33]. MULTIPleS is a 22 item scale de-
signed to measure the perceived impact of multi-
morbidity on patients emotional representations, and
perception of treatment burden, prioritising
conditions, causal links and activity limitations.
However, for the purpose of this study we have
removed the emotional representation subscale as
this would confound with other psychological variables
and reduced the scale to 16 items. Participants
were asked to state how much they agree these
16 statements on a four point scale where 0 indicates
strong disagreement and 3 indicates strong agreement. A
summary score was then calculated where a higher score
indicates greater perceived impact of multimorbidity.
There is evidence that illness perceptions about
multimorbidity predict outcomes [34].
Statistical analysis
Analysis was restricted to patients for whom a valid
PAM score could be derived. In the baseline question-
naire there was an error in the presentation of the PAM
questionnaire in that the ‘not applicable’ option was
omitted from eight out of the 13 items. However, ‘Not
applicable’ was only chosen by 5 % of respondents where
it was available as an option and therefore the impact of
this is likely to be small.
There was missing data for some patients across some
independent variables. To address this, for cases where
no more than one independent variable across the full
set was missing, logistic regression (linear, binary logistic,
ordinal logistic or multinomial as appropriate), was used
to impute the missing information, using the other eight
variables, plus the baseline PAM score, as predictors. In so
doing, 513 extra patients were included in the analyses.
Missing data on the PAM questionnaire was not imputed.
Descriptive statistics are used to characterise the dis-
tribution of PAM scores and PAM levels, and changes in
activation scores over time. Multiple linear regression
was used for all analyses. Initially, we investigated associ-
ations between baseline PAM scores and independent
variables. We examined Variance Inflation Factors (VIF)
across all models to eliminate collinear variables. All VIF
were below 10 and no variables were dropped from the
analyses on the basis of VIF. Both raw and standardised
regression coefficients are presented to determine the rela-
tive importance of each independent variable in addition to
the absolute effect. Prospective multiple regression analyses
considered whether these independent variables were
predictive of change in PAM scores over the 6 months
between the baseline and follow-up questionnaires. We
used analysis of change scores as this approach is less
bias than analysis of outcome at 6 months for use with
observational data [35]. All regression analyses were
clustered by general practice.
We repeated the analyses outlined above for the
subset of patients with at least two long-term condi-
tions (multimorbidity). The MULTIPleS scale was in-
cluded as an additional independent variable in these
analyses. Mean item imputation was used in order to
calculate a MULTIPleS score for those patients with
two or fewer items missing out of the original sixteen
MULTIPleS items.
Results
Descriptive data on PAM scores
The flow of participants is shown in Fig. 1. At baseline
4377 out of 12,989 (33.6 %) people returned a question-
naire. At 6 month follow up, 4225 were eligible to be
mailed and 3390 (80.2 %) were returned.
Participant characteristics at baseline are shown in
Table 1. The majority of participants were female, White
British, and retired or not otherwise working. Symptoms
of depression and anxiety were reported by 42.6 % of
participants and 60.1 % reported having 2 or more
long-term conditions.
A PAM score could be computed for a total of 3636
(83.1 %) participants at baseline. The mean PAM score
was 60.7 (sd 15.4) with the majority of participants
reporting PAM Level 3 (n = 1685, 46.3 %). Table 2 shows
participant characteristics by PAM level.
Change in PAM scores over 6 months
The overall correlation between baseline and follow up
PAM score was r = 0.43, p = 0.00. For those participants
who had a complete PAM score at baseline total PAM
scores varied between baseline and follow-up, decreasing
or increasing by up to 50 points (Table 3). For over half
of participants (52 %, n = 1392), PAM level remained
stable between the baseline and 6 month follow-up
questionnaires, increasing for 27 % (n = 718) of partici-
pants and decreasing for 21 % (n = 571). Participants
who scored at PAM level 4 on the baseline were those
more likely to remain at level 4 than to decrease by
6 month follow-up. Those who scored PAM levels 2 and
3 at baseline were the groups most likely to increase
their scores at follow-up with 40 % (n = 188) at level 2
reaching level 3 at follow up and another 10 % moving
up 2 levels to level 4 (Table 3).
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Predictors of Patient Activation at baseline
At baseline, patient activation was significantly lower
in older patients, those with depression, and those
with poor health literacy. Patient activation was
higher in those with good quality of life, living alone
and with better social support (Table 4). Depression
had the strongest association with patient activation.
Any self-reported impairment with health literacy
was associated with lower activation scores; there was
little difference in magnitude of effect between rarely
needing help when reading medical literature and
always needing help.
Predictors of patient activation at baseline in patients
with multimorbidity
In the subset of participants who self-reported 2 or more
long-term conditions, depression, being older, impaired
health literacy, HRQoL, social support, number of self-
reported comorbidities, and a greater perceived impact
of multimorbidity, were all significantly associated with
patient activation scores at baseline. Living alone and
being retired or not working were not significant for
those with multimorbidity (Table 4).
Predictors of change in patient activation scores over
6 months
Multivariate regression analysis of change in patient acti-
vation scores over 6 months across the whole sample
did not identify any significant predictors of patient acti-



























2 or more LTCs
1940(57.2%)
2 or more LTCs
Fig. 1 Flow of participants
Table 1 Participant characteristics
Continuous Variables n Mean SD
Age 4098 75 6.8
PAM Score
Baseline 3539 60.83 15.4
6 month Follow Up 2795 60.33 20.0
Depression 4123 67.1 22.4
MULTIPleSa
Summary Score 1703 35.6 9.1
Treatment Burden 1836 11.3 3.5
Prioritisation 1898 11.1 2.9
Causal Role 1831 6.3 2.2






1 LTC 1115 25.5 –
2 or more 2631 60.1
Ethnicity –





Working 206 4.9 –
Retired/not economically active 3985 93.8
Other 57 1.3
Health Literacyb –
Never needs help 2974 70.3
Rarely needs help 427 10.1
Sometimes needs help 455 10.8
Often needs help 158 3.7
Always needs help 215 5.1
Social Support –
Poor social support 1392 33.6
Good social support 2755 66.4
aMULTIPleS only for those who self-reported 2 or more LTCs
bSingle Item Literacy Screener (SILS)
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being depressed and being retired were significant pre-
dictors of change in patient activation scores (Table 5).
Discussion
Statement of principal findings
Although pilot data is being collected on the use of the
PAM, there is only limited published data on mixed
samples of less than 400 patients [36]. Using a large
cohort of older patients with long-term conditions, we
explored demographic and health related factors associ-
ated with patient activation scores. We found that the
most prominent factor associated with patient activation
is depression in both the group of patients with one
long-term condition and the subgroup of patients’ with
multimorbidity. Other factors associated with patient
activation were: older age, being retired, poor health
literacy, health-related quality of life, and social support.
The number of self-reported comorbidities and perceived
Table 2 Participant characteristics by level of patient activation
Demographic Variable PAM Level
Level 1 Level 2 Level 3 Level 4 Total
n
N % N % N % N % N %
Gender
Male 253 14.7 288 16.7 821 47.6 362 21.0 1724 47.8
Female 332 17.6 353 18.7 857 45.4 344 18.2 1886 52.2
Living alone
Yes 234 18.1 229 17.7 609 47.1 221 17.1 1293 35.9
No 351 15.2 411 17.8 1070 46.3 480 20.8 2312 64.1
Employment status
Working 13 7.6 24 13.9 86 50 49 28.5 172 4.6
Retired or not economically active 553 16.5 603 17.9 1552 46.3 646 19.3 3554 94.3
Other 15 36.6 4 9.8 17 41.5 5 12.2 41 1.1
Health Literacy
Never or rarely need help 317 11.2 494 17.4 1392 48.9 639 22.5 2842 80.5
Sometimes or often need help 108 29.1 77 20.8 150 40.4 36 9.7 371 10.5
Always need help 144 45.3 59 18.6 90 28.3 25 7.9 318 9.0
Social Support
Poor social support 251 22.1 226 19.9 517 45.5 142 12.5 1136 32.7
Good Social support 318 13.6 397 16.9 1092 46.6 535 22.8 2342 67.3
Depression
Not Depressed 180 8.8 309 15.1 1051 51.4 504 24.6 2044 57.2
Depressed 393 25.7 333 22.8 605 39.6 198 12.9 1529 42.8
Number of LTC1
LTC 2 or more 103 11.2 149 16.23 451 49.2 214 23.3 917 28.6
446 19.5 443 19.4 1019 44.6 376 16.5 2284 71.4
Continuous Variables Mean SD Mean SD Mean SD Mean SD Mean SD
Age in years 76.4 8.1 74.9 6.7 74.3 6.5 73.1 6.1 75 6.8
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impact of multimorbidity were also important for those
with more than one long-term condition. However, the ef-
fects of all factors (except depression) were small implying
that their impact on patient activation may not be clinic-
ally significant.
We explored predictors of change in patient activation
scores over 6 months. We did not identify any signifi-
cant predictors across the whole sample. However, in
the subset of patients with multimorbidity both depres-
sion and being retired or not working significantly pre-
dicted change in patient activation scores.
Strengths and weaknesses of the study
Study strengths included a large sample size, compre-
hensive measurement of patient-reported factors, and
longitudinal measurement allowing assessment of pre-
dictors of change in patient activation scores.
The cohort achieved a 34 % response rate. This is
similar to other studies in these populations using similar
methods, [25, 34, 37] but leaves significant potential for
non-response bias. The lack of data on non-respondents
makes it difficult to assess direction and magnitude of
bias. The data are therefore not a strong basis for assess-
ments of prevalence, and data such as the proportions at
each level of patient activation should be used with cau-
tion. Assessments of the relationships between measures
may be less vulnerable to non-response bias. Completion
of follow up was over 80 % and thus the potential for bias
here is less, although some scales (such as MULTIPleS)
did suffer additional missing data. The cohort is also lim-
ited to older patients and those living in one area in the
UK, which means that the results may not generalise.
Long-term conditions were self-reported and we did not
confirm diagnoses with medical records.
Comparison with other published data
Previous work in a cross sectional study found lower
patient activation scores to be associated with symp-
toms of depression and poor quality of life [38]. Our
study extends this by showing that depression predicts
change in patient activation scores over 6 months. A
longitudinal study found that patients with symptoms
of depression, even when subclinical, were less likely to
improve their activation scores or to engage in self-
Table 4 Results from multivariate regression analysis of patient activation score at baseline
All Participants ( N = 3293) Participants with >=2 LTCs (N = 1563)
Independent variable b 95% CI Beta (β) p b 95% CI Beta (β) p
Age -0.19 -0.26 to -0.11 -0.08 0.000 -0.16 -0.25 to -0.07 -0.08 0.001
Gender
Male
Female -0.72 -1.47 to 0.47 -0.02 0.095 -0.40 -1.65 to 0.86 -0.01 0.523
Living status
Living with others
Living alone 1.72 0.67 to 2.89 0.05 0.015 1.14 -0.63 to 2.91 0.04 0.199
Work status
Employed
Retired -0.31 -1.94 to 1.32 0.00 2.36 -2.25 to 6.97 0.03
Other 2.45 -3.36 to 8.26 0.00 0.437 6.67 -3.15 to 16.49 0.05 0.327
Health literacy
Never needs help
Rarely needs help -4.54 -6.09 to -2.98 -0.09
Sometimes needs help -4.58 -6.25 to -2.90 -0.09 -3.57 -5.66 to -1.48 -0.08
Often needs help -5.12 -7.82 to -2.41 -0.06 -5.61 -8.61 to -2.61 -0.08
Always needs help -9.56 -12.80 to -6.32 -0.13 0.000 -9.86 -13.94 to -5.78 -0.17 0.000
Number of LTC 0.03 -0.27 to 0.32 0.00 0.846 0.72 0.31 to 1.13 0.08 0.001
Depression 0.09 0.06 to 0.12 0.13 0.000 0.08 0.04 to 0.12 0.11 0.001
HRQoL 9.56 6.71 to 12.40 0.16 0.000 4.95 0.93 to 8097 0.09 0.017
Social Support 4.32 3.14 to 5.50 0.13 0.000 3.73 1.78 to 5.68 0.12 0.000
MULTIPleS - - - - -0.27 -0.40 to -0.13 -0.16 0.000
R2 0.168, Adjusted R20.164 R2 0.176, Adjusted R2 0.169
Blakemore et al. BMC Health Services Research  (2016) 16:582 Page 7 of 11
management behaviours over 6 months [39]. A large
longitudinal study of patient activation in US patients
with moderate to severe depression found that those
with more severe depression tended to be less activated
and that higher patient activation at baseline predicted
greater reduction in depression over 1 year [14]. Those
patients with the highest patient activation scores at
baseline had over twice the odds of remission from
depression.
In a cross sectional survey of US patients with multiple
sclerosis, patients’ level of education, as well as depression,
was found to be associated with patient activation [40].
Lower levels of education have previously been shown to
be associated with poor health literacy [41] which we
found to be significantly associated with patient activation
in our sample of older patients. A large Danish cohort
study of over 29,000 patients has shown that people with
long-term conditions have greater difficulties in under-
standing health information than the general population
and have greater problems choosing and engaging with
health care [42, 43].
We found that the total number comorbid long-term
conditions was associated with patient activation in the
short term, but did not predict change in activation
prospectively. A smaller US study of 850 patients with
multimorbidity over the age of 65 also found that number
of comorbid conditions was not related to patient activation
[16]. Although a crude count of the numbers of conditions
may not predict activation, we found that patient experi-
ence of multimorbidity, as measured by MULTIPleS, was
associated with patient activation and had the second stron-
gest association after depression.
Social support had a strong association with patient
activation across all patients. In a large cross sectional
survey of Danish patients with Type 2 diabetes greater
contact with friends was associated with higher patient
activation and having a poor functional social network
was associated with lower patient activation [44].
We found that living alone was associated with higher
patient activation in the short term. A systematic review
of studies on chronic illness self-management in people
living alone found that patients who live alone often en-
sure that they actively attend to their health needs as
they are required to manage their health independently
and often have no immediate help available to them [45].
Furthermore, those who live alone have been shown to
Table 5 Results from multivariate regression analysis of change in patient activation scores over 6 month follow up
All Participants (N = 2709) Participants with >=2 LTCs (N = 1273)
Independent variable b 95% CI Beta (β) p b 95% CI Beta (β) p
Age 0.03 -0.11 to 0.16 0.01 0.678 0.01 -0.12 to 0.15 0.01 0.851
Gender
Male
Female -0.23 -1.78 to 1.32 -0.01 0.762 -0.76 -2.85 to 1.33 -0.02 0.466
Living status
Living with others
Living alone -0.40 -2.21 to 1.40 -0.01 0.654 1.04 -0.72 to 2.80 0.03 0.239
Work status
Employed
Retired -3.44 -8.03 to 1.15 -0.04 -6.89 -12.74 to -1.03 -0.08
Other -4.59 -13.32 to 4.14 -0.02 0.259 -1.00 -12.88 to 10.88 -0.01 0.03
Health literacy
Never needs help
Rarely needs help 0.21 -2.66 to 3.10 0.00 -0.22 -3.43 to 2.99 0.00
Sometimes needs help 0.53 -1.44 to 2.50 0.01 -0.07 -2.77 to 2.62 0.00
Often needs help -1.25 -5.40 to 2.90 -0.01 -2.05 -6.99 to 2.89 0.03
Always needs help -1.20 -4.61 to 2.25 -0.11 0.824 -2.29 -6.12 to 1.54 0.03 0.665
Number of LTC 0.29 -0.20 to 0.78 0.02 0.242 -0.08 -0.82 to 0.64 0.01 0.807
Depression 0.33 -0.01 to 0.08 0.04 0.137 0.05 0.01 to 0.09 0.07 0.009
HRQoL -3.84 -8.15 to 0.46 -0.05 0.078 -0.46 -5.41 to 4.50 -0.01 0.852
Social Support -3.20 -1.90 to 1.25 0.01 0.683 0.73 -1.83 to 3.30 0.02 0.566
MULTIPleS - - - - 0.08 -0.04 to 0.21 0.04 0.160
R2 = 0.00, Adjusted R2 = 0.00 R2 0.01, Adjusted R2 = 0.00
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value social support outside the home and may actively
seek and maintain better social connections than those
with greater support in the home [45].
We found patient activation scores at 6 months were
moderately correlated with baseline scores, with fairly
significant movement between levels. It is complex to in-
terpret this change data, as it is not known what clinical
or other health and social care interventions were received
by patients. The entire local health economy was undergo-
ing a major re-organisation for this age group, but linking
that to changes in patient scores would be challenging.
The data do suggest some caution in using patient activa-
tion scores for very specific targeting of interventions,
given patient movement between levels of activation.
Meaning of the study: possible mechanisms and
implications for clinicians or policymakers
Our data suggest a cluster of characteristics that are associ-
ated with low activation, mainly depression but also other
demographic, social, educational, and health factors. If ef-
fective interventions are developed in the UK to improve
patient activation, these patients, and particularly those
with depression, may be usefully prioritised.
Additionally, the changeable factors which are associ-
ated with patient activation may suggest the potential
content of interventions. For example, interventions or
programmes will need to provide assistance with health
literacy (through education) and depression symptoms
(through web-based support or cognitive-behavioural
therapy interventions), and may usefully involve a compo-
nent around social support, particularly around increasing
functional social support. The associations with patient
experience of multimorbidity (MULTIPleS) highlight the
potential importance of the assessment of this issue in
patients [46].
Unanswered questions and future research
This study is unique because it presents the first as-
sessment of depression and patient activation in older
adults with long-term conditions. We found that de-
pression was significantly associated with patient acti-
vation and, for those patients with multimorbidity, it
predicted change in patient activation scores over
6 months. However, the opposite pattern of findings
has been shown in the literature; patient activation
predicted remission, response and changes in depres-
sion scores over 12 months in a large US sample of pa-
tients with moderate to severe depression [14]. Thus,
an unresolved research challenge is to fully understand
whether lower patient activation precedes depression
or depression leads to lower levels of patient activa-
tion. The examination of the temporal links between
depression and patient activation as part of a longitu-
dinal study with multiple follow-up assessment points
is a fruitful approach to disentangle the relationship
between depression and patient activation. This know-
ledge has the potential improve the effectiveness of
self-management interventions by timely and appropri-
ate management of depression and patient activation.
Moreover, much of the research to date on patient ac-
tivation has assessed the degree to which it is associated
with key outcomes, such as quality of life and costs.
Such might suggest two more specific causal functions
of activation.
First, activation may be a mediator of other outcomes,
[8] driving other outcomes. Intervening to improve acti-
vation may have effects on other outcomes further down
the causal pathway. For example, a self-management
intervention that raises a patient’s level of activation may
help them to better manage their long-term condition in
the short-term, leading to longer-term reductions in
costs and quality of life. Methods to assess mediation are
available, although they are complex, and often most
usefully done in the context of a trial [47].
Secondly, activation may be a moderator of other out-
comes [8]. If this is the case, then levels of activation will
influence the benefit that patients report from other in-
terventions, and assist in targeting. For example, a low-
intensity web-based self-management intervention may
demonstrate good outcomes with patients with a higher
level of activation, but may be ineffective with those with
lower activation, where a more intensive intervention
with greater professional input may be required. Again,
displaying such effects is possible but complex, and a
rigorous demonstration may require subgroup analyses
in a large trial or pooled analyses across several trials
[48]. The high levels of change in patient activation may
limit is utility as a moderator.
Conclusions
Older patients in the UK show variation in their levels
of activation. Activation is low in depressed, older, re-
tired patients with poor health literacy, and those who
lack social support. If activation is proven to be a useful
concept for targeting of interventions, our data may be
useful in identifying the sorts of patients who need acti-
vation, and may suggest hypotheses about ways of rais-
ing activation to improve outcomes. Further analyses of
longitudinal studies will be necessary to better under-
stand the causal relationships between patient activation
and variables such as depression.
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